Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Image Processing, Computer-Assisted | 7 | 2023 | 667 | 0.700 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2021 | 51 | 0.660 |
Why?
|
| Motion | 1 | 2016 | 59 | 0.500 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 7 | 2023 | 207 | 0.500 |
Why?
|
| Head | 1 | 2016 | 55 | 0.490 |
Why?
|
| Artifacts | 2 | 2016 | 128 | 0.480 |
Why?
|
| Brain | 4 | 2016 | 1554 | 0.480 |
Why?
|
| Radiopharmaceuticals | 4 | 2021 | 186 | 0.440 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2021 | 95 | 0.340 |
Why?
|
| Brain Diseases | 3 | 2002 | 75 | 0.210 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2023 | 51 | 0.200 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2002 | 7 | 0.190 |
Why?
|
| Toxoplasmosis, Cerebral | 1 | 2002 | 6 | 0.190 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2002 | 68 | 0.190 |
Why?
|
| Lymphadenopathy | 1 | 2021 | 23 | 0.180 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 1999 | 3 | 0.160 |
Why?
|
| Lymphoscintigraphy | 1 | 2016 | 6 | 0.130 |
Why?
|
| Sentinel Lymph Node | 1 | 2016 | 10 | 0.130 |
Why?
|
| Methylene Blue | 1 | 2016 | 22 | 0.130 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2016 | 40 | 0.130 |
Why?
|
| Coloring Agents | 1 | 2016 | 54 | 0.130 |
Why?
|
| Algorithms | 5 | 2016 | 1003 | 0.130 |
Why?
|
| Models, Anatomic | 1 | 2016 | 65 | 0.120 |
Why?
|
| Computer Simulation | 2 | 2016 | 477 | 0.120 |
Why?
|
| Gallium Radioisotopes | 2 | 2008 | 14 | 0.120 |
Why?
|
| Phantoms, Imaging | 3 | 2023 | 224 | 0.100 |
Why?
|
| Melanoma | 1 | 2016 | 331 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 414 | 0.090 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2009 | 44 | 0.090 |
Why?
|
| Heart | 2 | 2023 | 282 | 0.080 |
Why?
|
| Anthropometry | 1 | 2009 | 86 | 0.080 |
Why?
|
| Osteoarthropathy, Secondary Hypertrophic | 1 | 2008 | 2 | 0.080 |
Why?
|
| Mediastinal Neoplasms | 1 | 2008 | 20 | 0.080 |
Why?
|
| Positron-Emission Tomography | 1 | 2009 | 208 | 0.070 |
Why?
|
| Radioisotope Renography | 1 | 2007 | 4 | 0.070 |
Why?
|
| Neutron Activation Analysis | 1 | 2007 | 3 | 0.070 |
Why?
|
| Humans | 15 | 2023 | 62865 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 1 | 2007 | 112 | 0.070 |
Why?
|
| ROC Curve | 2 | 2023 | 279 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 162 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2007 | 174 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 2 | 1999 | 178 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 1140 | 0.050 |
Why?
|
| Thallium Radioisotopes | 1 | 2002 | 9 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 658 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 964 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 1078 | 0.040 |
Why?
|
| Cervical Vertebrae | 1 | 1999 | 106 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2009 | 608 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 82 | 0.030 |
Why?
|
| Levamisole | 1 | 1996 | 8 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 1996 | 16 | 0.030 |
Why?
|
| Female | 7 | 2016 | 32566 | 0.030 |
Why?
|
| Fluorouracil | 1 | 1996 | 66 | 0.030 |
Why?
|
| Hyponatremia | 1 | 1995 | 13 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2016 | 188 | 0.030 |
Why?
|
| Blindness | 1 | 1995 | 41 | 0.030 |
Why?
|
| Neoplasms | 2 | 2009 | 1350 | 0.030 |
Why?
|
| Adult | 3 | 2016 | 16672 | 0.030 |
Why?
|
| Middle Aged | 3 | 2016 | 17391 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2002 | 3263 | 0.030 |
Why?
|
| Aged | 5 | 2016 | 14268 | 0.030 |
Why?
|
| Male | 4 | 2016 | 29552 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 1996 | 661 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2009 | 90 | 0.020 |
Why?
|
| Remission, Spontaneous | 1 | 2008 | 14 | 0.020 |
Why?
|
| Lung | 1 | 1991 | 939 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2008 | 337 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2016 | 6545 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 2 | 1996 | 41 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 1640 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2000 | 293 | 0.010 |
Why?
|
| Body Constitution | 1 | 1999 | 16 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 1999 | 74 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 6195 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1996 | 220 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1996 | 337 | 0.010 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1991 | 11 | 0.010 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 1991 | 11 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 1991 | 30 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 1991 | 79 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 1991 | 190 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 1991 | 171 | 0.000 |
Why?
|
| Pneumonia | 1 | 1991 | 288 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1996 | 2150 | 0.000 |
Why?
|
| Animals | 1 | 1996 | 20620 | 0.000 |
Why?
|